Literature DB >> 12056642

Establishment and preliminary characterization of two cell lines derived from larynx carcinoma.

W Rzeski1, R Paduch, J Klatka, M Kandefer-Szerszeń, A Stepulak, P Pozarowski, B Zdzisińska.   

Abstract

Two new cell lines, designated as RK-33 and RK-45, have been successfully established by an outgrowth technique from two different larynx tumours obtained from patients after laryngectomy. Both cell lineshave been maintained incultureforover 18 monthsandrecently have reached passage number 220 (RK-33) and 110 (RK-45). The cells display an epithelial morphology and multiply with a population doubling time of about 24 h (RK-33) and about 40 h (RK-45). The epithelial nature of the cells was also confirmed by expression of cytokeratins 8 and 18. Both lines were sensitive to antiproliferative effect of the tested cytostatic agents such as methotrexate. etoposide and thiotepa, with methotrexate being the most effective. We believe that both cell lines: RK-33 and RK-45 could be a suitable model for studying larynx cancer biology, however, further characterization of their properties is needed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12056642

Source DB:  PubMed          Journal:  Folia Histochem Cytobiol        ISSN: 0239-8508            Impact factor:   1.698


  3 in total

1.  Differential molecular response of larynx cancer cell lines to combined VPA/CDDP treatment.

Authors:  Ewelina Gumbarewicz; Przemko Tylżanowski; Jarogniew Łuszczki; Joanna Kałafut; Arkadiusz Czerwonka; Justyna Szumiło; Anna Wawruszak; Krzysztof Kupisz; Krzysztof Polberg; Jolanta Smok-Kalwat; Andrzej Stepulak
Journal:  Am J Cancer Res       Date:  2021-06-15       Impact factor: 6.166

2.  Histone Deacetylase Inhibitor SAHA as Potential Targeted Therapy Agent for Larynx Cancer Cells.

Authors:  Aneta Grabarska; Jarogniew J Łuszczki; Ewa Nowosadzka; Ewelina Gumbarewicz; Witold Jeleniewicz; Magdalena Dmoszyńska-Graniczka; Krystyna Kowalczuk; Krzysztof Kupisz; Krzysztof Polberg; Andrzej Stepulak
Journal:  J Cancer       Date:  2017-01-01       Impact factor: 4.207

3.  Imperatorin as a Promising Chemotherapeutic Agent Against Human Larynx Cancer and Rhabdomyosarcoma Cells.

Authors:  Aneta Grabarska; Krystyna Skalicka-Woźniak; Michał Kiełbus; Magdalena Dmoszyńska-Graniczka; Paulina Miziak; Justyna Szumiło; Ewa Nowosadzka; Krystyna Kowalczuk; Sherief Khalifa; Jolanta Smok-Kalwat; Janusz Klatka; Krzysztof Kupisz; Krzysztof Polberg; Adolfo Rivero-Müller; Andrzej Stepulak
Journal:  Molecules       Date:  2020-04-28       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.